N. Crucinio

Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases.

A. Facciorusso, V. Del Prete, N. Muscatiello, 2016, World journal of gastroenterology.

Post-recurrence survival in hepatocellular carcinoma after percutaneous radiofrequency ablation.

M. Barone, A. Di Leo, B. Carr, 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Intrahepatic Cholangiocarcinoma and Thermal Ablation: Long-term Results of An Italian Retrospective Multicenter Study

A. Giorgio, V. Giorgio, P. Gatti, 2019, Journal of clinical and translational hepatology.

Conditional survival analysis of hepatocellular carcinoma patients treated with radiofrequency ablation

M. Barone, A. Di Leo, A. Facciorusso, 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

Serum ferritin as a new prognostic factor in hepatocellular carcinoma patients treated with radiofrequency ablation

M. Barone, A. Di Leo, B. Carr, 2014, Journal of gastroenterology and hepatology.

Prognostic role of 25‐hydroxyvitamin D in patients with liver metastases from colorectal cancer treated with radiofrequency ablation

M. Barone, A. Facciorusso, V. Del Prete, 2016, Journal of gastroenterology and hepatology.

Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patients

M. Barone, A. Di Leo, B. Carr, 2015, Journal of gastroenterology and hepatology.

Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patients

M. Barone, A. Di Leo, B. Carr, 2015, Journal of gastroenterology and hepatology.